文献速递神经创伤神经重症

重型创伤性脑损伤需去骨瓣减压术患者异常血液学参数的预后意义

Prognostic significance of abnormal hematological parameters in severe traumatic brain injury requiring decompressive craniectomy.
PubMed 文献 · J Neurosurg · 2019-02-08

这项回顾性队列研究纳入2004至2016年澳大利亚西部388例重型创伤性脑损伤后行去骨瓣减压术的患者,比较入院血液学异常与IMPACT预后模型对18个月神经功能结局的预测能力。151例(38.9%)结局不良;单独分析时INR的判别能力最佳,但校正IMPACT预测风险后各参数均未提供额外预后信息。

要点

  • 388例中151例(38.9%)在去骨瓣减压术后18个月结局不良。
  • 单独分析时INR判别能力最佳(AUROC 0.645,p=0.001)。
  • 校正IMPACT预测风险后血液学参数未提供额外预后信息。

核心结论

  • 在需要去骨瓣减压术的重型创伤性脑损伤中,单独分析时INR是最佳的血液学预后参数,尤其在排除使用华法林的患者后。
  • 入院血液学异常的预后意义大多已被IMPACT预后模型所涵盖,未提供超出IMPACT预测风险的额外预后信息。
  • 作者认为,新的创伤性脑损伤预后因素应与经验证的综合预后模型(如IMPACT预后模型)的预测风险联合评估。

研究设计与样本

  • 回顾性队列研究,纳入2004至2016年澳大利亚西部388例重型创伤性脑损伤后需行去骨瓣减压术的患者。
  • 比较入院血液学异常与IMPACT预后模型预测18个月神经功能结局的能力,采用受试者工作特征曲线下面积(AUROC)评估判别能力。

主要发现

  • 388例中151例(38.9%)在去骨瓣减压术后18个月结局不良(死亡、植物状态或严重残疾)。
  • 入院血红蛋白(AUROC 0.594,p=0.002)、血糖(AUROC 0.592,p=0.002)、纤维蛋白原(AUROC 0.563,p=0.036)、INR(AUROC 0.645,p=0.001)、活化部分凝血活酶时间(AUROC 0.564,p=0.033)及弥散性血管内凝血评分(AUROC 0.623,p=0.001)均与18个月结局不良风险升高相关。
  • 中性粒细胞与淋巴细胞比值与结局不良风险无显著相关(AUROC 0.500,p=0.998)。
  • 校正IMPACT预测风险后,上述参数及血小板计数均与结局不良无显著相关(风险每增加10%的OR 2.473,95%CI 2.061-2.967;p=0.001)。
  • 排除伤前使用华法林的8例(2.1%)后,校正IMPACT预测风险后INR似与部分额外预后意义相关(OR 3.183,95%CI 0.856-11.833;p=0.084)。

临床怎么用

  • 作者认为,新的创伤性脑损伤预后因素应与经验证的综合预后模型(如IMPACT预后模型)的预测风险联合评估。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Hematological abnormalities after severe traumatic brain injury (TBI) are common, and are associated with a poor outcome. Whether these abnormalities offer additional prognostic significance over and beyond validated TBI prognostic models is uncertain. METHODS: This retrospective cohort study compared the ability of admission hematological abnormalities to that of the IMPACT (International Mission for Prognosis and Analysis of Clinical Trials) prognostic model to predict 18-month neurological outcome of 388 patients who required a decompressive craniectomy after severe TBI, between 2004 and 2016, in Western Australia. Area under the receiver operating characteristic (AUROC) curve was used to assess predictors' ability to discriminate between patients with and without an unfavorable outcome of death, vegetative state, or severe disability. RESULTS: Of the 388 patients included in the study, 151 (38.9%) had an unfavorable outcome at 18 months after decompressive craniectomy for severe TBI. Abnormalities in admission hemoglobin (AUROC 0.594, p = 0.002), plasma glucose (AUROC 0.592, p = 0.002), fibrinogen (AUROC 0.563, p = 0.036), international normalized ratio (INR; AUROC 0.645, p = 0.001), activated partial thromboplastin time (AUROC 0.564, p = 0.033), and disseminated intravascular coagulation score (AUROC 0.623, p = 0.001) were all associated with a higher risk of unfavorable outcome at 18 months after severe TBI. As a marker of inflammation, neutrophil to lymphocyte ratio was not significantly associated with the risk of unfavorable outcome (AUROC 0.500, p = 0.998). However, none of these parameters, in addition to the platelet count, were significantly associated with an unfavorable outcome after adjusting for the IMPACT predicted risk (odds ratio [OR] per 10% increment in risk 2.473, 95% confidence interval [CI] 2.061-2.967; p = 0.001). After excluding 8 patients (2.1%) who were treated with warfarin prior to the injury, there was a suggestion that INR was associated with some additional prognostic significance (OR 3.183, 95% CI 0.856-11.833; p = 0.084) after adjusting for the IMPACT predicted risk. CONCLUSIONS: In isolation, INR was the best hematological prognostic parameter in severe TBI requiring decompressive craniectomy, especially when patients treated with warfarin were excluded. However, the prognostic significance of admission hematological abnormalities was mostly captured by the IMPACT prognostic model, such that they did not offer any additional prognostic information beyond the IMPACT predicted risk. These results suggest that new prognostic factors for TBI should be evaluated in conjunction with predicted risks of a comprehensive prognostic model that has been validated, such as the IMPACT prognostic model.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Corbett JM, Ho KM, Honeybul S, et al. Prognostic significance of abnormal hematological parameters in severe traumatic brain injury requiring decompressive craniectomy. J Neurosurg. 2019. PMID: 30738401. doi:10.3171/2018.10.JNS182293

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。